Greenway Greenhouse Cannabis Corporation (CSE:GWAY)

Revenue by Segment

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Pharmaceuticals	8.95M	5.23M	5.62M	1.98M	-
Pharmaceuticals Growth	71.10%	-6.97%	183.32%	-	-
Total	8.95M	5.23M	5.62M	1.98M	-
Total Growth	71.10%	-6.97%	183.32%	-	-

Revenue by Geography

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Canada	8.95M	5.23M	5.62M	1.98M	-
Canada Growth	71.10%	-6.97%	183.32%	-	-
Total	8.95M	5.23M	5.62M	1.98M	-
Total Growth	71.10%	-6.97%	183.32%	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 17, 2026

Data Sources Report a data error